Gapping down
In reaction to disappointing earnings/guidance:
- API -4.8%, KC -2.8%, GDS -2.6%, PEIX -2.5%, FN -2.1%, ADCT -1.3%, BHP -1.1%, WMT -0.6%, BEST -0.5%
Other news:
- PSTX -22.8% (FDA places trial for P-PSMA-101 on clinical hold to investigate patient death)
- CNK -4.6% (convertible notes offering)
- PEB -3.4% (provides update on Q3 operating trends)
- CALM -3.3% (stock offering)
- ZI -3.3% (commences secondary offering of 12 mln shares of common stock by selling stockholders)
- KDP -3.2% (stock offering)
- TBIO -2.3% (stock offering)
- SPT -2.2% (prices 6.9 mln share offering at $27.50/sh)
- MIDD -2.1% (convertible notes offering)
- AMH -1.8% (prices offering of 13,000,000 common shares for expected gross proceeds of approximately $364.0 mln)
- FUTU -1.8% (stock offering)
- LUV -0.8% (stock offering)
Analyst comments:
- UBX -4.3% (downgraded to Neutral from Buy at Citigroup; downgraded to Equal-Weight from Overweight at Morgan Stanley)